Literature DB >> 18305561

Gefitinib potentiates myeloid cell differentiation by ATRA.

M B Miranda, R Duan, S M Thomas, J R Grandis, R L Redner, J E Jones, D E Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18305561      PMCID： PMC2596306          DOI： 10.1038/leu.2008.28

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

Review 1.  Signal transduction pathways that contribute to myeloid differentiation.

Authors:  M B Miranda; D E Johnson
Journal:  Leukemia       Date:  2007-04-19       Impact factor: 11.528

2.  A small molecule-kinase interaction map for clinical kinase inhibitors.

Authors:  Miles A Fabian; William H Biggs; Daniel K Treiber; Corey E Atteridge; Mihai D Azimioara; Michael G Benedetti; Todd A Carter; Pietro Ciceri; Philip T Edeen; Mark Floyd; Julia M Ford; Margaret Galvin; Jay L Gerlach; Robert M Grotzfeld; Sanna Herrgard; Darren E Insko; Michael A Insko; Andiliy G Lai; Jean-Michel Lélias; Shamal A Mehta; Zdravko V Milanov; Anne Marie Velasco; Lisa M Wodicka; Hitesh K Patel; Patrick P Zarrinkar; David J Lockhart
Journal:  Nat Biotechnol       Date:  2005-02-13       Impact factor: 54.908

3.  Gefitinib induces myeloid differentiation of acute myeloid leukemia.

Authors:  Kimberly Stegmaier; Steven M Corsello; Kenneth N Ross; Jenny S Wong; Daniel J Deangelo; Todd R Golub
Journal:  Blood       Date:  2005-07-05       Impact factor: 22.113

Review 4.  The design of selective and non-selective combination therapy for acute promyelocytic leukemia.

Authors:  Y Jing; S Waxman
Journal:  Curr Top Microbiol Immunol       Date:  2007       Impact factor: 4.291

5.  Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer.

Authors:  A J Barker; K H Gibson; W Grundy; A A Godfrey; J J Barlow; M P Healy; J R Woodburn; S E Ashton; B J Curry; L Scarlett; L Henthorn; L Richards
Journal:  Bioorg Med Chem Lett       Date:  2001-07-23       Impact factor: 2.823

6.  Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.

Authors:  M B Miranda; T F McGuire; D E Johnson
Journal:  Leukemia       Date:  2002-04       Impact factor: 11.528

7.  A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients.

Authors:  Z X Chen; Y Q Xue; R Zhang; R F Tao; X M Xia; C Li; W Wang; W Y Zu; X Z Yao; B J Ling
Journal:  Blood       Date:  1991-09-15       Impact factor: 22.113

8.  Inhibition of Src family kinases enhances retinoic acid induced gene expression and myeloid differentiation.

Authors:  Michelle B Miranda; Robert L Redner; Daniel E Johnson
Journal:  Mol Cancer Ther       Date:  2007-12-07       Impact factor: 6.261
  8 in total
  7 in total

1.  A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia.

Authors:  Daniel J Deangelo; Donna Neuberg; Philip C Amrein; Jacob Berchuck; Martha Wadleigh; L Andres Sirulnik; Ilene Galinsky; Todd Golub; Kimberly Stegmaier; Richard M Stone
Journal:  Leuk Res       Date:  2013-11-05       Impact factor: 3.156

2.  MEK/ERK dependent activation of STAT1 mediates dasatinib-induced differentiation of acute myeloid leukemia.

Authors:  Yanfen Fang; Like Zhong; Meihua Lin; Xinglu Zhou; Hui Jing; Meidan Ying; Peihua Luo; Bo Yang; Qiaojun He
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

3.  Lapatinib induces autophagy, apoptosis and megakaryocytic differentiation in chronic myelogenous leukemia K562 cells.

Authors:  Huey-Lan Huang; Yu-Chieh Chen; Yu-Chuen Huang; Kai-Chien Yang; Hsin yi Pan; Shou-Ping Shih; Yu-Jen Chen
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

4.  Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia.

Authors:  Yu-Jen Chen; Li-Wen Fang; Wen-Chi Su; Wen-Yi Hsu; Kai-Chien Yang; Huey-Lan Huang
Journal:  Onco Targets Ther       Date:  2016-07-20       Impact factor: 4.147

5.  Pardaxin Promoted Differentiation and Maturation of Leukemic Cells via Regulating TLR2/MyD88 Signal against Cell Proliferation.

Authors:  Wu-Ching Uen; Chen-Yen Choong; Chen-Jei Tai; Cheng-Jeng Tai
Journal:  Evid Based Complement Alternat Med       Date:  2019-02-24       Impact factor: 2.629

6.  Ganoderma lucidum Polysaccharides Induce Macrophage-Like Differentiation in Human Leukemia THP-1 Cells via Caspase and p53 Activation.

Authors:  Jia-Wei Hsu; Hsuan-Cheng Huang; Shui-Tein Chen; Chi-Huey Wong; Hsueh-Fen Juan
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-04       Impact factor: 2.629

7.  Dasatinib accelerates valproic acid-induced acute myeloid leukemia cell death by regulation of differentiation capacity.

Authors:  Sook-Kyoung Heo; Eui-Kyu Noh; Dong-Joon Yoon; Jae-Cheol Jo; Jae-Hoo Park; Hawk Kim
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.